Cytek Biosciences Inc expected to post breakeven results a share - Earnings Preview

Cytek Biosciences

10/05/2022 03:03

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to report
results on May 11.
    * The Fremont California-based  company is expected to
report
revenue of $32.508 million, according to the mean estimate from
3 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Cytek Biosciences
Inc is
for breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $17​, above​ its last closing price of $7.82. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.02        0.03       0.03      Met     20
 Sep. 30 2021  0.03        0.02       0.02      Met     -14.3
 Jun. 30 2021  0.02        0.02       0.00      Missed  -100​
 ​​                                                     
                                                        ​
 This summary was machine generated May 10 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated